Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Braz. j. otorhinolaryngol. (Impr.) ; 88(6): 932-936, Nov.-Dec. 2022. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1420781

ABSTRACT

Abstract Introduction: The Epley maneuver is applied in the treatment of benign paroxysmal positional vertigo, the BPPV. However, dizziness and balance problems do not improve immediately after the treatment. Objective: In this study, the effectiveness of the head-shaking maneuver before the Epley maneuver was investigated in the treatment of BPPV. Methods: Between March 2020 and August 2020, ninety-six patients with posterior semicircular canal BPPV were analyzed prospectively. The patients were divided into two groups: patients who underwent the Epley maneuver only in the treatment (Group 1) and patients who underwent the Epley maneuver after the head-shaking maneuver (Group 2). The results of the Berg balance scale and dizziness handicap index were evaluated before the treatment and at the first week after the treatment. Results: The improvement in functional, emotional, and physical dizziness handicap index and Berg balance scale values after the treatment was found to be statistically significant in both groups. It was determined that the change in functional and physical dizziness handicap index and Berg balance scale values of the patients in Group 2 was statistically higher than those in Group 1. Although, the change in emotional dizziness handicap index values in Group 2 was higher than those in Group 1, no statistical significance was found between the groups. Conclusion: As a result of our hypothesis, we think that in the treatment of posterior semicircular canal BPPV, the otoliths adhered to the canal can be mobilized by the head-shaking maneuver, and this will contribute to the increase of the effectiveness of the Epley maneuver.


Resumo Introdução: A manobra de Epley é aplicada no tratamento da vertigem posicional paroxística benigna (VPPB). Entretanto, a tontura e os problemas de equilíbrio não melhoram imediatamente após o tratamento. Objetivo: Investigar a eficácia da manobra de balançar a cabeça antes da manobra de Epley no tratamento da VPPB. Método: De março de 2020 a agosto de 2020, 96 pacientes com VPPB de canal semicircular posterior foram analisados prospectivamente. Os pacientes foram divididos em dois grupos: pacientes que foram submetidos apenas à manobra de Epley no tratamento (Grupo 1) e pacientes que foram submetidos à manobra de Epley após a manobra de balanço da cabeça (Grupo 2). Os resultados da escala de equilíbrio de Berg e do dizziness handicap index foram avaliados antes do tratamento e na primeira semana após o tratamento. Resultados: A melhoria nos valores funcionais, emocionais e físicos do dizziness handicap index e da escala de equilíbrio de Berg após o tratamento foi estatisticamente significante em ambos os grupos. Foi determinado que a alteração nos valores funcionais e físicos do dizziness handicap indexe da escala de equilíbrio de Berg dos pacientes do Grupo 2 foi significantemente maior do que aqueles do Grupo 1. Embora a alteração nos valores do dizziness handicap index emocional no Grupo 2 tenha sido maior do que no Grupo 1, não houve significância estatística entre os grupos. Conclusão: Como resultado de nossa hipótese, acreditamos que no tratamento da VPPB do canal semicircular posterior os otólitos aderidos ao canal podem ser mobilizados através da manobra de balanço da cabeça, o que contribuirá para o aumento da eficácia da manobra de Epley.

2.
Braz J Otorhinolaryngol ; 88(6): 932-936, 2022.
Article in English | MEDLINE | ID: mdl-33642216

ABSTRACT

INTRODUCTION: The Epley maneuver is applied in the treatment of benign paroxysmal positional vertigo, the BPPV. However, dizziness and balance problems do not improve immediately after the treatment. OBJECTIVE: In this study, the effectiveness of the head-shaking maneuver before the Epley maneuver was investigated in the treatment of BPPV. METHODS: Between March 2020 and August 2020, ninety-six patients with posterior semicircular canal BPPV were analyzed prospectively. The patients were divided into two groups: patients who underwent the Epley maneuver only in the treatment (Group 1) and patients who underwent the Epley maneuver after the head-shaking maneuver (Group 2). The results of the Berg balance scale and dizziness handicap index were evaluated before the treatment and at the first week after the treatment. RESULTS: The improvement in functional, emotional, and physical dizziness handicap index and Berg balance scale values after the treatment was found to be statistically significant in both groups. It was determined that the change in functional and physical dizziness handicap index and Berg balance scale values of the patients in Group 2 was statistically higher than those in Group 1. Although, the change in emotional dizziness handicap index values in Group 2 was higher than those in Group 1, no statistical significance was found between the groups. CONCLUSION: As a result of our hypothesis, we think that in the treatment of posterior semicircular canal BPPV, the otoliths adhered to the canal can be mobilized by the head-shaking maneuver, and this will contribute to the increase of the effectiveness of the Epley maneuver.


Subject(s)
Benign Paroxysmal Positional Vertigo , Dizziness , Humans , Benign Paroxysmal Positional Vertigo/therapy , Dizziness/therapy , Physical Therapy Modalities , Treatment Outcome , Semicircular Canals
3.
Turk Patoloji Derg ; 37(2): 106-114, 2021.
Article in English | MEDLINE | ID: mdl-33973644

ABSTRACT

OBJECTIVE: Although squamous cell carcinomas (SCCs) originating from different anatomic localizations display a similar histological appearance under light microscopy, they may differ in terms of epigenetic and genetic features. The aim of this study was to analyze mir-126, mir-182, and mir-486-5p expression levels in head and neck SCCs and lung SCCs, and to identify localization-specific miRNA expression profiles. MATERIAL AND METHOD: The expression levels of mir-126, mir-182, and mir-486-5p were analyzed in lung, oral cavity, laryngeal, and hypopharyngeal SCCs in 40 patients, using quantitative real-time polymerase chain reaction. RESULTS: The findings showed that lung, oral cavity, laryngeal, and hypopharyngeal SCCs have distinct mir-126 and mir-486-5p expression profiles. It was also observed that mir-126 and mir-486-5p expression levels were highly specific to the tumor localization. CONCLUSION: These findings highlighted that SCCs originating from different anatomic localizations have different miRNA expression profiles. miRNA expression analysis can be used to predict the primary localizations of those SCCs.


Subject(s)
Biomarkers, Tumor/genetics , Head and Neck Neoplasms/genetics , Lung Neoplasms/genetics , MicroRNAs/genetics , Squamous Cell Carcinoma of Head and Neck/genetics , Adult , Aged , Aged, 80 and over , Female , Gene Expression Profiling , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/surgery , Humans , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Squamous Cell Carcinoma of Head and Neck/pathology , Squamous Cell Carcinoma of Head and Neck/surgery , Transcriptome
4.
J Craniofac Surg ; 32(3): e298-e301, 2021 May 01.
Article in English | MEDLINE | ID: mdl-33252531

ABSTRACT

BACKGROUND: It has been reported worldwide that patients with a diagnosis of COVID-19 usually suffer a loss of smell and taste. In this study, we aimed to evaluate the relationship between the severity of the disease and the loss of smell and taste. In addition, we evaluated patients' smell and taste functions after recovery. METHODS: Between March and May 2020, 418 patients diagnosed with COVID-19 were divided into 3 groups: home-quarantined, hospitalized, and intensive care patients. The disease, smell, and taste functions of patients were evaluated with visual analog scores before diagnosis of COVID-19, during the disease, and fourth week after recovery. The types of smell loss and types of taste flavor loss occurring during the disease were questioned. RESULTS: In all 3 groups, changes in smell and taste loss during the disease were statistically detected (P = 0.001). The smell loss rates determined in groups 1 to 3 were 45%, 43.7%, and 31.2%, respectively. The taste loss rates determined in groups 1 to 3were 46.6%, 32.1%, and 31.2% respectively. The rate of patients with a total recovery of smell loss in groups 1 to 3 were 95.5%, 93.7%, and 100%, respectively (P = 0.768). The rate of patients with a total recovery of taste loss in groups 1 to 3 were 97.1%, 91.4%, and 100%, respectively (P = 0.423). CONCLUSION: COVID-19 causes significant loss of smell and taste in patients. The loss of smell and taste does not correlate with the severity of COVID-19 disease. The loss of smell and taste improves at a high rate after the disease.


Subject(s)
COVID-19 , Olfaction Disorders , Cross-Sectional Studies , Humans , Olfaction Disorders/diagnosis , Olfaction Disorders/etiology , SARS-CoV-2 , Smell , Taste , Taste Disorders/diagnosis , Taste Disorders/etiology
5.
Oral Oncol ; 114: 105089, 2021 03.
Article in English | MEDLINE | ID: mdl-33189577

ABSTRACT

It is well known that head and neck squamous cell carcinomas are characterized by genetic alterations, genomic instability and different immune defects and Telomerase reverse transcriptase promoter mutations have been found with high rates in patients with tongue squamous cell carcinomas. We presented a non-smoker, no alcohol consuming woman who had a second primary tongue SCC after four and a half years later of her first tongue SCC with TERT promoter mutation. The primary tumor and its recurrences in woman with tongue SCC who have never smoked and had no alcohol consumption may need to be differing from other tongue carcinomas. TERT promoter mutations may have a relation in etiopathogenesis of tumor and mutations need to be on mind in future studies.


Subject(s)
Mutation , Neoplasms, Second Primary/genetics , Squamous Cell Carcinoma of Head and Neck/genetics , Telomerase/genetics , Tongue Neoplasms/genetics , Aged, 80 and over , Female , Humans , Neoplasms, Second Primary/metabolism , Neoplasms, Second Primary/pathology , Promoter Regions, Genetic , Squamous Cell Carcinoma of Head and Neck/metabolism , Telomerase/metabolism , Tongue Neoplasms/metabolism , Tongue Neoplasms/pathology
6.
Head Neck ; 42(11): 3446-3459, 2020 11.
Article in English | MEDLINE | ID: mdl-32812307

ABSTRACT

BACKGROUND: Postoperative radioactive iodine (RAI) administration is widely utilized in patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to recognize the potential negative sequelae of this treatment. The prevention, diagnosis, and management of the salivary and lacrimal complications of RAI exposure are addressed in this consensus statement. METHODS: A multidisciplinary panel of experts was convened under the auspices of the American Head and Neck Society Endocrine Surgery and Salivary Gland Sections. Following a comprehensive literature review to assess the current best evidence, this group developed six relevant consensus recommendations. RESULTS: Consensus recommendations on RAI were made in the areas of patient assessment, optimal utilization, complication prevention, and complication management. CONCLUSION: Salivary and lacrimal complications secondary to RAI exposure are common and need to be weighed when considering its use. The recommendations included in this statement provide direction for approaches to minimize and manage these complications.


Subject(s)
Nuclear Medicine , Ophthalmology , Otolaryngology , Thyroid Neoplasms , Consensus , Humans , Iodine Radioisotopes/adverse effects , Salivary Glands , Thyroid Neoplasms/radiotherapy , Thyroid Neoplasms/surgery , United States
7.
Acta Cytol ; 64(5): 498-506, 2020.
Article in English | MEDLINE | ID: mdl-32454502

ABSTRACT

BACKGROUND: Primary synovial sarcoma (SS) of the thyroid (PSST) is extremely rare. Its differential diagnosis from other neoplasms is essential since it has different management protocols and prognosis. CASE: A 26-year-old man with a 4.5-cm solid lobulated mass was seen at an outside hospital. Fine needle aspiration (FNA) was interpreted as a papillary carcinoma, and a total thyroidectomy was performed. The final histologic diagnosis was spindle epithelial tumor with thymus-like differentiation (SETTLE). No metastases were detected at that time, and the patient received radioactive iodine treatment. Two years post-surgery, he was seen at our hospital with a local recurrence, and FNA was considered as consistent with SETTLE. The mass was resected, and a left modified radical neck dissection was performed. The tumor revealed necrosis and a high mitotic index. Following histologic, immunohistochemical, and molecular studies, the tumor was classified as a PSST. The patient received chemotherapy and targeted immunotherapy, but he died 41 months after the initial presentation. CONCLUSION: The main diagnostic pitfall of PSST is SETTLE. The presence of mitotic figures and basal lamina material, negative staining for smooth muscle actin, and positive staining for transducer-like enhancer of split 1 antibody favor SS over SETTLE. SYT gene rearrangement is essential to establish the definitive diagnosis of PSST.


Subject(s)
Carcinoma, Papillary/diagnosis , Neoplasms, Glandular and Epithelial/diagnosis , Sarcoma, Synovial/diagnosis , Thymus Neoplasms/diagnosis , Thyroid Neoplasms/diagnosis , Adult , Carcinoma, Papillary/therapy , Diagnosis, Differential , Fatal Outcome , Humans , Male , Neoplasms, Glandular and Epithelial/therapy , Sarcoma, Synovial/therapy , Thymus Neoplasms/therapy , Thyroid Neoplasms/therapy
8.
Ear Nose Throat J ; 99(5): 323-326, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31637949

ABSTRACT

The use of hearing aid (HA) may improve the hearing performance and ease the perceived negative consequences of hearing difficulties in elderly individuals. The aim of this study was to determine the problems experienced by elderly individuals with HA and to investigate the factors that could increase the use of HA. A total of 122 female and 127 male patients with a mean age of 76.79 ± 6.91 years who were recommended HA were evaluated. The following details were taken from the patients: age, gender, duration of hearing complaint, whether or not they received HA, number of family members, number of hours they used HA in a day, type of device, number of ears with HA, educational status, whether they continued to work, whether they were tested before taking the device, the reasons for not taking HA, and the reasons that reduce their use of HA. A total of 18 patients did not receive HA for the following reasons: 9 considered HA too expensive, 8 thought it would be difficult to use HA, and 1 did not like it because of its appearance. No significant difference was found in the patients' daily HA use duration, age, sex, number of immediate family members, education level, type of device, test before taking the device, and use of HA in single ear or bilateral ears. There was a significant difference in the daily HA use duration and whether the patients continued to work. We need to help reduce the problems associated with the use of HA to help older individuals have a more active role in society and help them in their health problems.


Subject(s)
Correction of Hearing Impairment/instrumentation , Hearing Aids/statistics & numerical data , Hearing Loss, Bilateral/rehabilitation , Hearing Loss, Sensorineural/rehabilitation , Patient Acceptance of Health Care/statistics & numerical data , Aged , Aged, 80 and over , Correction of Hearing Impairment/psychology , Female , Hearing Aids/psychology , Hearing Loss, Bilateral/psychology , Hearing Loss, Sensorineural/psychology , Humans , Male , Patient Acceptance of Health Care/psychology , Retrospective Studies
9.
Cytopathology ; 31(1): 26-34, 2020 01.
Article in English | MEDLINE | ID: mdl-31630464

ABSTRACT

BACKGROUND: Invasive diagnostic methods, such as punch biopsies, have a potential to produce undesirable side effects in the larynx, such as scarring and vocal dysfunction. This study is an attempt to assess the diagnostic potential of cytology to efficiently diagnose premalignant and malignant laryngeal lesions, while sparing patients the risk of complications of punch biopsies. METHODS: Laryngeal smears, using endocervical-type brushes, and punch biopsies were procured from each patient. Smears were prepared and the brush was cut and put in Surepath preservative solution for cytological analysis and human papillomavirus (HPV) DNA testing. A Real-TM Quant kit that detects 14 HPV types was used for genotyping. Immunohistochemical staining for p16 was performed on cytological and histological specimens. RESULTS: Cytological diagnosis was correct in 84.6%, 100% and 100% of cases with a histological diagnosis of squamous cell carcinomas, high-grade squamous intraepithelial lesions and benign lesions, respectively. However, cytological interpretation was correct only in 25% of low-grade squamous intraepithelial lesions. HPV DNA test was positive in only one case, which was a laryngeal polyp. Testing for p16 was negative in all the cytological and histological material. CONCLUSION: Laryngeal cytology is a useful diagnostic tool in establishing the diagnosis of high-grade squamous epithelial cell abnormalities. Recognition of low-grade lesions, however, is challenging. HPV genotyping and p16 staining do not seem to be helpful ancillary techniques in cytological material procured from the larynx.


Subject(s)
Cyclin-Dependent Kinase Inhibitor p16/metabolism , Laryngeal Neoplasms/metabolism , Laryngeal Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Alphapapillomavirus/genetics , Alphapapillomavirus/pathogenicity , Biopsy/methods , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , Cytodiagnosis/methods , Cytological Techniques/methods , DNA, Viral/genetics , Female , Humans , Laryngeal Neoplasms/virology , Male , Middle Aged , Papillomavirus Infections/metabolism , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Precancerous Conditions/metabolism , Precancerous Conditions/pathology , Precancerous Conditions/virology , Prospective Studies , Squamous Intraepithelial Lesions/metabolism , Squamous Intraepithelial Lesions/pathology , Squamous Intraepithelial Lesions/virology , Young Adult
10.
Turk Arch Otorhinolaryngol ; 57(2): 75-80, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31360924

ABSTRACT

OBJECTIVE: We aimed to present the long-term outcomes and sialendoscopic findings in only patients with sialolithiasis and ductal scars in idiopathic chronic recurrent sialadenitis who experienced unsuccessful results with conservative treatment and were treated with sialendoscopy. METHODS: We retrospectively analyzed the patients with a diagnosis of only sialolithiasis and ductal scars in chronic recurrent sialadenitis who underwent sialendoscopy between January 2011 and June 2016. We collected clinical and intraoperative data including patient age, sex, date of the procedure, the involved gland, operative findings and complications. Follow-up data included whether the symptoms were resolved or recurred and whether any further procedures were performed. RESULTS: Of a total of 38 patients, 16 were excluded from the study due to missing clinical or follow-up data, and analysis was conducted on 22 patients. Twelve were diagnosed with sialolithiasis, while the remaining 10 were diagnosed with idiopathic chronic sialadenitis and had ductal scars. Stone sizes ranged from 2 mm to 10 mm. Mean follow-up time was 39.5 months. The final success rate was 100%. Of the 10 patients with ductal scarring, five had scar in the parotid gland duct, and five in the submandibular gland duct. The mean follow-up time of all ductal scar patients was 47.1 months. The final success rate was 70%. CONCLUSION: Sialendoscopy is a minimally invasive method for the diagnosis and treatment of sialolithiasis and ductal scars of the salivary glands after failure of conservative treatments in adults.

11.
PLoS One ; 13(10): e0205077, 2018.
Article in English | MEDLINE | ID: mdl-30289952

ABSTRACT

PURPOSE: Human papillomavirus (HPV) infected oropharyngeal squamous cell carcinoma (OPSCC) patients have a better prognosis compared to HPV(-) counterparts. However, a subset of HPV(+) patients with a smoking history fail to respond to the standard of care treatments such as radiation and chemotherapy. To understand the underlying mechanism driving HPV(+) OPSCC patient resistance to treatment and recurrence, we sought to identify and characterize the differentially expressed miRNAs and their target genes in HPV(+) smokers and non-smokers. EXPERIMENTAL DESIGN: MicroRNA expression analysis was performed using Nanostring in tumor tissues isolated from a prospective cohort of HPV(+) smoking (n = 9) and HPV(+) (n = 13) non-smoking OPSCC patients. Identified miRNAs of interest were further validated using qRT-PCR in cigarette smoke extract (CSE) treated HPV(+) and E6/E7 overexpressing HPV(-) cells. RESULTS: In comparison to OPSCC HPV(+) non-smokers, 38 miRNAs were significantly altered in the HPV(+) smoker patients cohort and out of that 9 were downregulated. Altered miRNA expression was also detected in the serum and metastatic lymph nodes of HPV(+) smokers versus non-smokers. Expression of miR-133a-3p was significantly downregulated in OPSCC smokers, HPV(+) cells and E6/E7 overexpressing HPV(-) cells treated with CSE. Reduction of miR-133a-3p induced the upregulation of miR-133a-3p target mRNAs EGFR and HuR. CONCLUSIONS: Our results indicate that miR-133a-3p is a target of smoking-induced changes in HPV(+) patients and alters the expression of EGFR and HuR which may promote HPV associated oropharyngeal cancer. Therefore, future treatment strategies for HPV(+) OPSCC smokers should focus on EGFR inhibition and the development of selective therapies to target HuR.


Subject(s)
MicroRNAs/metabolism , Oropharyngeal Neoplasms/metabolism , Papillomavirus Infections/metabolism , Smoking/adverse effects , Smoking/metabolism , Adult , Aged , Cell Line, Tumor , Cohort Studies , ELAV-Like Protein 1/metabolism , ErbB Receptors/metabolism , Female , Gene Expression Regulation, Neoplastic , Humans , Male , Middle Aged , Oropharyngeal Neoplasms/complications , Oropharyngeal Neoplasms/pathology , Papillomaviridae , Papillomavirus Infections/complications , Papillomavirus Infections/pathology , Prospective Studies , RNA, Messenger/metabolism , Smoking/pathology , Tobacco Smoke Pollution/adverse effects
12.
Oral Oncol ; 82: 53-60, 2018 07.
Article in English | MEDLINE | ID: mdl-29909902

ABSTRACT

OBJECTIVES: To evaluate the demographics, clinical features, survival outcomes, and prognostic indicators of patients with acinic cell carcinoma (ACC) of the parotid gland with emphasis on the roles of grade, tumor size, and nodal status in survival. MATERIALS AND METHODS: A retrospective analysis of cases diagnosed between 2004 and 2012 from the National Cancer Database was performed. Multivariable logistic regression was used to determine factors associated with survival. RESULTS: 2362 cases were identified. Most patients were females (61.3%) and Caucasian (85.4%) with a median age of 54 years (range, 18-90 years). Most tumors were <3 cm in size (75.8%). Regional metastases and high-grade histology were rare (8.2%, 5.1%). All patients received surgery as primary treatment with 42.7% of patients receiving adjuvant radiation therapy or chemoradiotherapy. 5 year overall survival was 88.6%. On multivariable analysis, age >70 years (hazard ratio [HR]: 10.05, 95% confidence interval [CI]: 5.64-17.91), high-grade (HR: 5.30, 95% CI: 3.39-8.29), tumor size of 3 to 6 cm (HR: 1.53, 95% CI: 1.10-2.12), tumor size >6 cm (HR: 2.98, 95% CI: 1.681-5.289), pN2+ (HR: 3.14, 95% CI: 2.10-4.69), T4 (HR: 2.89, 95% CI: 1.74-4.80) were significant prognosticators. CONCLUSION: Although patients with ACC generally are considered to have a favorable prognosis, an aggressive subgroup with poor outcomes was identified. This group is characterized by high-grade, advanced T classification, tumors larger than 3 cm, with regional metastases and age greater than 70 years. Histologic grade is a substantially stronger predictor of survival than T and N classifications.


Subject(s)
Carcinoma, Acinar Cell/pathology , Databases, Factual , Parotid Neoplasms/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Acinar Cell/radiotherapy , Carcinoma, Acinar Cell/surgery , Female , Humans , Male , Middle Aged , Parotid Neoplasms/radiotherapy , Parotid Neoplasms/surgery , Prognosis , Retrospective Studies , Survival Analysis , Treatment Outcome , Young Adult
13.
JAMA Otolaryngol Head Neck Surg ; 143(11): 1092-1097, 2017 11 01.
Article in English | MEDLINE | ID: mdl-28975191

ABSTRACT

Importance: The clinical implications of extracapsular dissection over superficial parotidectomy are controversial and limited in data on cost-effectiveness. Objective: To compare extracapsular dissection with superficial parotidectomy for benign parotid tumors with respect to surgical outcomes and cost-effectiveness. Design, Setting, and Participants: This was a retrospective medical record review and cost-effectiveness analysis performed from August 2012 to November 2015 at a tertiary care institution. Adult patients (age ≥18 years) who underwent parotidectomy for benign parotid lesions were included. Exposures: Treatment by extracapsular dissection or superficial parotidectomy. Main Outcomes and Measures: Differences in postoperative complication rates and health services outcomes, including procedure time, anesthesia time, length of stay, and charges for surgeon, anesthesia, operating room, and hospital. Results: A total of 46 parotidectomies consisting of 26 extracapsular dissections and 20 superficial parotidectomies met criteria. Of the 46 patients, 33 were women. Patient ages ranged from 18 to 83 years. Lesion features were similar between groups with most being pleomorphic adenoma. Procedure time (effect size, -1.31; 95% CI, -1.93 to -0.65), anesthesia time (effect size, -1.37; 95% CI, -1.99 to -0.70), and length of stay (effect size, -0.66; 95% CI, -1.25 to -0.05) were significantly shorter for extracapsular dissection compared with superficial parotidectomy. Moreover, anesthesia (effect size, -1.55; 95% CI, -2.19 to -0.86), operating room (effect size, -1.09; 95% CI, -1.69 to -0.45), and total hospital charges (effect size, -1.13; 95% CI, -1.74 to -0.49) were significantly less for extracapsular dissection while remaining charges, including surgeon, showed no difference. Finally, facial nerve weakness, great auricular nerve dysesthesia, and other relevant postoperative complications were comparable between groups. Conclusions and Relevance: In the hands of an experienced surgeon, extracapsular dissection is a shorter, less costly, and equally safe alternative to traditional superficial parotidectomy when treating benign parotid lesions. Further follow-up is needed to ensure these perceived advantages are maintained over time.


Subject(s)
Parotid Neoplasms/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Cost-Benefit Analysis , Female , Hospital Charges , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Operative Time , Parotid Neoplasms/pathology , Postoperative Complications , Retrospective Studies , Treatment Outcome
14.
Eur Arch Otorhinolaryngol ; 274(7): 2921-2926, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28439692

ABSTRACT

The aim of the present study was to evaluate the role of HPV in laryngeal squamous cell carcinoma and correlate it with patients' clinicopathological data. In total, 78 laryngeal squamous cell carcinoma patients enrolled in this study. The presence of genotype-specific HPV DNA was evaluated using Genotyping Assay in formalin-fixed paraffin-embedded tissue which was diagnosed between 2005 and 2015. All samples were also evaluated for p16 immunohistochemical staining. HPV DNA and p16 status were assessed in terms of location, smoking, alcohol consumption, lymph node status, tumor stage, overall survival, disease-free survival, perineural invasion, and vascular invasion retrospectively. Five test samples were excluded from the study due to inadequate deoxyribonucleic acid purity. HPV DNA was detected in 19 of 73 (26.02%) in patients with laryngeal squamous cell carcinoma. Human papilloma virus genotyping revealed double human papilloma virus in one case (types 16 and 59) and HPV 16 in the remaining cases. Although HPV-positive cases showed slightly better 3 years survival than HPV-negative ones, this finding was not statistically significant (overall survival p = 0.417, HPV positive: 92.3%, HPV negative: 81.4%, and disease-free survival p = 0.526, HPV positive: 93.8%, HPV negative: 80.9%). The presence of HPV DNA was not significantly associated with any clinicopathological features (p > 0.05). Among 73 patients, only 4 had an immunohistochemical staining of p16 and these patients were also HPV DNA 16 positive. Although our study results revealed a slightly better survival in patients with HPV DNA positivity for HPV 16 compared to the negative ones, the difference was not statistically significant. However, an increasing rate in especially high-risk-type HPV-16 prevalence in laryngeal squamous cell carcinoma by RT-PCR method was observed compared to our previous study. Although the presence of HPV in laryngeal SCCs seems to be associated with slightly better prognosis, additional studies may be needed, since our results were not statistically significant. We believed that HPV is not an adequate biomarker for diagnostic and prognostic purposes in laryngeal squamous cell carcinoma.


Subject(s)
Carcinoma, Squamous Cell , Human papillomavirus 16/genetics , Laryngeal Neoplasms , Papillomavirus Infections , Adult , Aged , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/virology , DNA, Viral/analysis , Disease-Free Survival , Female , Humans , Laryngeal Neoplasms/epidemiology , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/virology , Larynx/pathology , Male , Middle Aged , Papillomavirus Infections/epidemiology , Papillomavirus Infections/virology , Prognosis , Reproducibility of Results , Retrospective Studies , Risk Factors , Turkey/epidemiology
15.
Oral Oncol ; 67: 192-197, 2017 04.
Article in English | MEDLINE | ID: mdl-28351576

ABSTRACT

Ectomesenchymal chondromyxoid tumors are rare, benign neoplasms of the head and neck most commonly found within the oral cavity. While histopathological evaluation has been the primary focus of prior studies, clinical characterization of this rare entity currently remains sparse. Thus, this study was performed to provide insights into the clinical characteristics of ectomesenchymal chondromyxoid tumors to aid clinicians in distinguishing the lesion from other benign and malignant processes for a more accurate diagnosis and treatment. Moreover, this study includes a unique case of ectomesenchymal chondromyxoid tumor arising in the base of tongue, now the fourth to arise at that anatomic site. Including this case, a systematic review of the literature identified only 60 individual cases reported thus far. This study provides a detailed analysis of all 60 cases including demographics, clinical presentation, radiographic imaging, follow-up, and recurrence rate.


Subject(s)
Mesenchymoma/pathology , Tongue Neoplasms/pathology , Adolescent , Adult , Aged , Biopsy , Child , Female , Humans , Male , Mesenchymoma/diagnostic imaging , Mesenchymoma/surgery , Middle Aged , Tongue Neoplasms/diagnostic imaging , Tongue Neoplasms/surgery , Young Adult
16.
Laryngoscope ; 127(2): E62-E66, 2017 02.
Article in English | MEDLINE | ID: mdl-27545281

ABSTRACT

OBJECTIVES/HYPOTHESIS: We aimed to determine the microRNA-21 expression in laryngeal squamous cell carcinoma and assess the association between the disease and clinical characteristics of patients. STUDY DESIGN: Retrospective case-control study. METHODS: A retrospective study was conducted from January 2005 to May 2011, in a tertiary hospital following tumor resection in 72 patients with laryngeal squamous cell carcinoma. We used formalin-fixed paraffin-embedded tissue samples of laryngeal squamous cell carcinomas (study group) and adjacent nontumor tissues (control group) for microRNA-21 expressions, and we successfully extracted microRNAs detectable by real-time polymerase chain reaction. All patients were evaluated separately, and the study and control groups were compared. The study group was assessed in terms of localization, smoking, alcohol consumption, lymph node staging, tumor stage, overall survival, disease-free survival, perineural, and vascular invasion. RESULTS: All patients were male, and the average age of patients was 64.2 ± 10.3 years. MicroRNA-21 was upregulated in laryngeal squamous cell carcinomas compared to adjacent nontumor tissues (P = .005). However, the microRNA-21 did not differ significantly according to any clinicopathological features (P > .05). MicroRNA-21 has been found to be expressed at lower levels in early stage (stages 1 and 2) compared with advanced stage (stages 3 and 4), but this was not statistically significant (P = .455). CONCLUSIONS: We conclude that the microRNA-21 level may play an important role in diagnosis and serve as a potential biomarker; such measurement thus has clinical applications. However, any possible prognostic associations with microRNA-21 levels should be re-evaluated in future studies on laryngeal squamous cell carcinoma samples amenable to retrospective analysis. LEVELS OF EVIDENCE: NA Laryngoscope, 2016 127:E62-E66, 2017.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/genetics , Laryngeal Neoplasms/diagnosis , Laryngeal Neoplasms/genetics , MicroRNAs/genetics , Aged , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Case-Control Studies , Humans , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging , Prognosis , Real-Time Polymerase Chain Reaction , Retrospective Studies , Statistics as Topic , Survival Analysis
17.
Eur Arch Otorhinolaryngol ; 274(3): 1747-1750, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28004263

ABSTRACT

Pediatric robotic surgery is a relatively new technology that has been shown to be safe and feasible for a number of pediatric procedures. Our literature analysis was performed using Pubmed database between January 2005 and December 2015, using key words: "robotic," "robotic surgery," "TORS," "pediatric," "children," "head and neck," and "da Vinci". We selected only publications in English. Eight published reports met the selection criteria. We totally found 41 patients, and the age range was between 2 months and 19 years. The cases are 16 only lingual tonsillectomy, nine base of tongue and lingual tonsillectomy, two malignant disease in the oropharynx (high-grade undifferentiated sarcoma and biphasic synovial sarcoma), one tongue base thyroglossal duct cyst, 11 laryngeal cleft cyst, one posterior glottic stenosis, and one congenital true vocal cord paralysis surgeries. One intraoperative complication was reported. No patient needed postoperative tracheotomy. Hospital duration time had a range of 1-16 days. TORS is new for pediatric patients in head and neck areas, and there were few reports. It is becoming increasingly used in head and neck surgeries and those reports above are encouraging for pediatric robotic airway surgeries in otolaryngology in the future.


Subject(s)
Otorhinolaryngologic Diseases/surgery , Otorhinolaryngologic Surgical Procedures , Robotic Surgical Procedures , Age Factors , Child , Female , Humans , Male , Otorhinolaryngologic Diseases/etiology , Otorhinolaryngologic Diseases/pathology
18.
Eur Arch Otorhinolaryngol ; 273(12): 4501-4506, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27324888

ABSTRACT

This study was aimed to evaluate the efficacy of treatment modalities for minimizing salivary gland damage caused by radiotherapy. Forty rats were divided into five groups. Group 1 had no irradiation or any treatment. Group 2 underwent only 15 Gy single dose radiotherapy. N-acetylcysteine, dexamethasone, hyperbaric oxygen treatment were given, respectively to the group 3, 4 and 5 for 5 days. 15 Gy single dose radiotherapy was applied to the group 3, 4 and 5 on the second day. Pyknosis, lysis, and vacuolization were examined in ductal cells and pyknosis, lysis, vacuolization, inflammation and collective duct damage in acinar cells. Dexamethasone and hyperbaric oxygen did not prove to have a positive effect on acinar and ductal cell. N-acetylcysteine-applied group had statistically significantly lower amount of damage. We determined that the decrease of ductal and acinar cell damage in parotid glands of N-acetylcysteine-applied rats was more distinct and statistically.


Subject(s)
Acetylcysteine/therapeutic use , Dexamethasone/therapeutic use , Glucocorticoids/therapeutic use , Hyperbaric Oxygenation , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/therapeutic use , Salivary Glands/radiation effects , Animals , Male , Parotid Gland/radiation effects , Radiation Dosage , Radiotherapy/adverse effects , Random Allocation , Rats , Rats, Wistar
19.
J Voice ; 30(6): 721-725, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26277074

ABSTRACT

OBJECTIVES: Smoking is one of the most common harmful habits in the world, especially common among young adult male population in Turkey. The purpose of this study was to evaluate the effect of smoking on the young adults' male voice using multidimensional voice assessment methods. STUDY DESIGN: This is a case-control study. METHODS: The study included 109 young adult men, 51 nonsmokers and 58 smokers between the ages of 20 and 34 years. The voice evaluation protocol consisted of voice handicap index (VHI), maximum phonation time (MPT), and perceptual, acoustic, and videostroboscopic analyses. RESULTS: A statistically significant increase for physical, physiological, and total scores of VHI was found in smokers group (P < 0.05). MPT showed significantly lower values among smokers (P < 0.05). There were no significant changes in perceptual analysis of voice samples between smoker and nonsmoker groups. There were no significant changes in any of the acoustic parameters between smoker and nonsmoker groups. Results of videostroboscopic analysis showed significant relationships between smoking and increased vocal fold erythema (P < 0.05). In addition, significantly asymmetry, amplitude, and periodicity abnormality of vocal fold movements were observed in smoker group during phonation (P < 0.05). CONCLUSIONS: The results of this study indicate that observable signs of laryngeal irritation and disturbed phonatory physiology occur even in young adults with relatively brief smoking habits. Subjective symptoms of smoking on voice appear to occur earlier than objective findings.


Subject(s)
Laryngeal Diseases/etiology , Phonation , Smoking/adverse effects , Speech Acoustics , Voice Disorders/etiology , Voice Quality , Acoustics , Adult , Age Factors , Disability Evaluation , Humans , Judgment , Laryngeal Diseases/diagnosis , Laryngeal Diseases/physiopathology , Male , Predictive Value of Tests , Risk Factors , Sex Factors , Sound Spectrography , Speech Perception , Speech Production Measurement , Speech-Language Pathology/methods , Stroboscopy , Surveys and Questionnaires , Time Factors , Turkey , Video Recording , Voice Disorders/diagnosis , Voice Disorders/physiopathology , Young Adult
20.
Head Neck ; 38 Suppl 1: E535-41, 2016 04.
Article in English | MEDLINE | ID: mdl-25810124

ABSTRACT

BACKGROUND: Tumor necrosis factor-related associated-inducing ligand (TRAIL) is a death ligand currently under clinical trials for laryngeal carcinoma. METHODS: Paraffin-embedded tissues from 40 patients with laryngeal carcinoma and 20 patients with benign laryngeal pathologies were retrospectively analyzed using immunohistochemistry in terms of distribution and intensity, and for final analysis of immunoreactivity of receptors, H-score was used. The study group was assessed in terms of localization, lymph node staging, tumor stage, overall survival, disease-free survival, locoregional control, perineural invasion, and vascular invasion. RESULTS: The H-score of decoy-R2 (DcR2) staining were increased significantly in tumor tissue (p = .04). A significantly greater increase in terms of H-score of DR5 receptor staining (p = .06) was detected in tumor tissue. CONCLUSION: TRAIL-mediated gene therapy may not be effective. Indeed, the findings may indicate treatment resistance. TRAIL and TRAIL receptor levels were not associated with prognosis © 2015 Wiley Periodicals, Inc. Head Neck 38: E535-E541, 2016.


Subject(s)
Laryngeal Neoplasms/metabolism , Receptors, TNF-Related Apoptosis-Inducing Ligand/metabolism , TNF-Related Apoptosis-Inducing Ligand/metabolism , Tumor Necrosis Factor Decoy Receptors/metabolism , Adult , Aged , Apoptosis , Disease-Free Survival , Female , Humans , Immunohistochemistry , Laryngeal Neoplasms/diagnosis , Male , Middle Aged , Neoplasm Staging , Prognosis , Retrospective Studies , Tumor Necrosis Factor-alpha
SELECTION OF CITATIONS
SEARCH DETAIL
...